Discover predictions for upcoming dividend increases from top companies with long-term growth. Learn which stocks to watch ...
We recently published a list of 15 Dividend Zombies to Invest in. In this article, we are going to take a look at where ...
Colgate-Palmolive outperforms its peers in terms of profitability, with a strong gross profit margin and a high return on ...
Diamond Hill Capital, an investment management company, released its “Large Cap Strategy” fourth-quarter 2024 investor letter ...
We recently published a list of the 12 Best Household Stocks to Buy According to Hedge Funds. In this article, we are going ...
StockNews.com lowered shares of Colgate-Palmolive (NYSE:CL – Free Report) from a buy rating to a hold rating in a research ...
Barclays analyst Lauren Lieberman maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of $89.00.
Barclays raised the firm’s price target on Colgate-Palmolive (CL) to $89 from $83 and keeps an Equal Weight rating on the shares. Ahead of Q1 ...
Analysts expect a meagre 1.5% revenue growth and 1% volume growth for Colgate Palmolive in the fourth quarter.
Getting dozens of ad agency partners around the world to work together is like herding cats – but Colgate-Palmolive was able ...
In the past two months, shares of Colgate Palmolive (India), the market leader in oral care in the country, has ...
In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against other dividend zombies to invest in. The broader market has posted consecutive annual gains ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results